本文選題：冠心病 + 血清堿性磷酸酶�。� 參考：《蚌埠醫(yī)學(xué)院》2017年碩士論文

【摘要】：目的:回顧性分析血清堿性磷酸酶(ALP)水平與冠心病(CHD)的相關(guān)性,及其對CHD進(jìn)行危險(xiǎn)分層的價(jià)值。方法:采集因胸痛、胸悶住院并行冠狀動(dòng)脈造影檢查的研究對象314例,收集他們的年齡、性別、血壓等一般資料及肝功能、腎功能、血脂、血糖等實(shí)驗(yàn)室生化檢查資料。根據(jù)冠狀動(dòng)脈造影結(jié)果確診CHD221例,其中穩(wěn)定型心絞痛(SAP)62例、不穩(wěn)定型心絞痛(UAP)89例和急性心肌梗死(AMI)70例。CHD組中,ALP升高者51例,ALP正常者170例。據(jù)Gensini評分記錄冠狀動(dòng)脈狹窄程度,Gensini40為嚴(yán)重狹窄組,有151例。據(jù)Rentrop分級評價(jià)冠狀動(dòng)脈側(cè)支循環(huán)(CCC)情況,Rentrop 0-1級為冠狀動(dòng)脈側(cè)支循環(huán)受損,有112例。并隨訪半年,記錄CHD組主要心血管不良事件(MACCE)的發(fā)生情況�；仡櫺苑治鯝LP水平與CHD的臨床分型、冠脈病變程度、冠脈側(cè)支循環(huán)及發(fā)生MACCE的相關(guān)性,并分析ALP與其他傳統(tǒng)指標(biāo)的關(guān)聯(lián),探討ALP水平與CHD的相關(guān)性。結(jié)果:1.ALP濃度升高者共為59例,檢出率為18.79%。其中CHD組51例,異常率為23.08%;非CHD組8例,異常率為8.6%。前者明顯高于后者,差異有統(tǒng)計(jì)學(xué)意義,x2值為4.738,P0.05。ALP升高者中男性50例,檢出率84.7%;女性9例,檢出率15.3%。差異無統(tǒng)計(jì)學(xué)意義,P0.05。2.CHD組在男性、年齡、吸煙、高血壓、血糖、總膽固醇、甘油三酯、低密度脂蛋白、C反應(yīng)蛋白、ALP水平均高于非CHD組,CHD組高密度脂蛋白水平低于非CHD組,僅年齡、高血壓、血糖、C-反應(yīng)蛋白、高密度脂蛋白、ALP水平差別有統(tǒng)計(jì)學(xué)意義。多變量logistic回歸分析結(jié)果表明ALP水平升高是CHD的獨(dú)立影響因素(OR1.027,95%CI 1.013-1.040,P0.05)。3.ALP水平在冠狀動(dòng)脈嚴(yán)重狹窄組(101.3±50.6U/L)非嚴(yán)重狹窄組(78.0±38.8U/L),差異有統(tǒng)計(jì)學(xué)意義,P0.05。采用多變量logistic回歸分析結(jié)果表明ALP水平升高是冠狀動(dòng)脈狹窄的獨(dú)立影響因素(OR1.013,95%CI 1.103-1.023,P0.05)。4.ALP水平在多支血管病變組(80.80±29.37U/L)雙支血管病變組(76.53±18.15U/L)單支血管病變組(73.95±23.15U/L),差別無統(tǒng)計(jì)學(xué)意義,P0.05。5.ALP水平在SAP組(78.08±50.05U/L)、UAP組(80.08±48.80U/L)、AMI組(79.80±50.30U/L)無明顯差異。6.CHD組中有112例(51%)觀察到CCC受損。ALP水平和CCC受損分級之間有相關(guān)性,高ALP水平與CCC受損相關(guān)(65%vs 51%,p=0.03)7.單變量回歸分析表明,糖尿病、高血壓、年齡和ALP水平是影響CHD發(fā)生MACCE的因素。多變量logistic回歸分析結(jié)果表明ALP水平升高是CHD發(fā)生MACCE的獨(dú)立影響因素(OR1.112,95%CI 1.203-1.623,P0.05)。8.ALP水平與冠脈狹窄積分、高血壓、C-反應(yīng)蛋白呈正相關(guān),r值分別是0.452、0.166、0.387。結(jié)論:1.血清ALP水平與CHD呈正相關(guān),它可能是CHD的獨(dú)立危險(xiǎn)因素。2.ALP水平還與冠狀動(dòng)脈狹窄程度相關(guān),可能是反映冠狀動(dòng)脈病情嚴(yán)重程度的一個(gè)指標(biāo)。3.ALP水平可用與評估CCC是否受損。4.ALP升高可作為CHD發(fā)生MACCE的危險(xiǎn)因素之一。5.ALP水平與C-反應(yīng)蛋白呈線性正相關(guān)。
[Abstract]:Objective: to retrospectively analyze the correlation between serum alkaline phosphatase (ALP) level and coronary heart disease (CHD), and the value of risk stratification in CHD. Methods: 314 patients with chest pain and chest tightness were examined by coronary angiography, and their age, sex, blood pressure, liver function, renal function, blood lipid, blood sugar and other laboratory biochemical data were collected. According to the results of coronary angiography, there were 62 cases of stable angina pectoris, 89 cases of unstable angina pectoris and 70 cases of acute myocardial infarction AMI. According to Gensini score, coronary artery stenosis was recorded as severe stenosis group (151 cases). According to the Rentrop classification, the CCCs of coronary collateral circulation were evaluated. Rentrop 0-1 grade was damaged in the collateral circulation of coronary artery, there were 112 cases. The incidence of major adverse cardiovascular events (MAC) in CHD group was recorded after half a year follow-up. The correlation between ALP level and clinical type of CHD, severity of coronary artery disease, collateral circulation of coronary artery and occurrence of MACCE was analyzed retrospectively. The correlation between ALP and other traditional indexes was analyzed, and the correlation between ALP level and CHD was discussed. Results: 1. The ALP concentration was increased in 59 cases, and the detection rate was 18.79%. The abnormal rate was 23.08 in CHD group and 8.6 in non- group. The former was significantly higher than the latter, and the difference was statistically significant (P 0.05. 05.ALP 4.738g) in 50 males (84.7%) and 9 females (15.3%). There was no significant difference in the levels of CHD, age, smoking, hypertension, blood glucose, total cholesterol, triglyceride, low density lipoprotein C-reactive protein (LDL-C) in CHD group compared with that in non-CHD group. There were significant differences in ALP levels among hypertension, glucose C-reactive protein and high density lipoprotein. The results of multivariate logistic regression analysis showed that the increase of ALP level was an independent factor of CHD. The CI 1.013-1.040 P0.05U 路3.ALP level was significantly higher in the coronary artery stenosis group (101.3 鹵50.6 UL / L) than in the non-severe stenosis group (78.0 鹵38.8 UL / L, P 0.05). Multivariate logistic regression analysis showed that elevated ALP level was an independent influencing factor for coronary artery stenosis (CI 1.103-1.023 P0.05N .4.ALP level was 80.80 鹵29.37U / L in multivessel disease group) and 76.53 鹵18.15U / L group in single vessel disease group (73.95 鹵23.15U / L), there was no significant difference. There was no significant difference in P0.05.ALP level between SAP group (78.08 鹵50.05U / L) and SAP group (80.08 鹵48.80U / L + 58.80U / L). High ALP level is associated with CCC damage. Univariate regression analysis showed that diabetes, hypertension, age and ALP levels were the factors influencing MACCE in CHD. Multivariate logistic regression analysis showed that the increase of ALP level was the independent influencing factor of MACCE in CHD. The correlation between the level of ALP and coronary stenosis score was 0.203 ~ 1.623 (P < 0.05), and the positive correlation value of C-reactive protein in hypertension was 0.452n0.166n 0.387, respectively. Conclusion 1. Serum ALP level was positively correlated with CHD, which may be an independent risk factor for CHD. 2. ALP level was also correlated with coronary artery stenosis. ALP level may be a marker of severity of coronary artery disease. 3. ALP level can be used to evaluate whether CCC is damaged or not. 4. ALP elevation may be one of the risk factors for MACCE in CHD. 5. ALP level is linearly correlated with C- reactive protein.
【學(xué)位授予單位】：蚌埠醫(yī)學(xué)院
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R541.4

【參考文獻(xiàn)】

相關(guān)期刊論文 前8條

1 劉相應(yīng);唐良秋;徐新;張社兵;;心型脂肪酸結(jié)合蛋白在急性心肌梗死中的應(yīng)用[J];中國心血管病研究;2015年07期

2 劉延青;馮長州;孫淑艷;;心型脂肪酸結(jié)合蛋白在胸痛6h內(nèi)診斷急性心肌梗死的meta分析[J];中國實(shí)驗(yàn)診斷學(xué);2015年01期

3 張健;李春盛;;心型脂肪酸結(jié)合蛋白在心梗患者行介入治療中的意義[J];中華急診醫(yī)學(xué)雜志;2013年06期

4 李美芹;蔣知新;衣志勇;孫玉發(fā);王雙雙;;心型脂肪酸結(jié)合蛋白對急性心肌梗死的早期診斷價(jià)值[J];中國老年學(xué)雜志;2013年04期

5 沈健;羅素新;馬康華;覃數(shù);;急性心肌梗死生化標(biāo)志物的研究進(jìn)展[J];心血管病學(xué)進(jìn)展;2012年01期

6 楊喜山;代琳琳;董平栓;何海超;張東江;席歡;;心型脂肪酸結(jié)合蛋白對急性心肌梗死的早期診斷價(jià)值[J];中國心血管病研究;2012年01期

7 潘柏申;心肌損傷標(biāo)志物的研究進(jìn)展與心肌梗死診斷標(biāo)準(zhǔn)的修訂[J];臨床檢驗(yàn)雜志;2002年03期

8 褚沛;張翠杰;鞏亞奇;孫永錫;張磊;王文進(jìn);;心臟型脂肪酸結(jié)合蛋白在急性心肌梗死早期診斷中的臨床應(yīng)用價(jià)值[J];中國急救醫(yī)學(xué);2009年02期

，

本文編號：1815243